Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011, Article ID 631079, 4 pages
http://dx.doi.org/10.1155/2011/631079
Case Report

Development of Cutaneous Leishmaniasis after Leishmania Skin Test

1Serviço de Imunologia, Hospital Universitário Prof. Edgard Santos, Universidade Federal da Bahia, Salvador, BA 40000, Brazil
2Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais, CNPq/MCT, Salvador, BA 40000, Brazil
3Cursos de Medicina e Biomedicina, Escola Bahiana de Medicina e Saúde Pública, Salvador, BA 40000, Brazil
4Centro de Pesquisas Gonçalo Moniz, LASP, Fundação Oswaldo Cruz, Salvador, BA 40000, Brazil

Received 26 May 2011; Revised 1 September 2011; Accepted 1 September 2011

Academic Editor: Abhay R. Satoskar

Copyright © 2011 Paulo R. Machado et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. C. Jones, W. D. Johnson, A. C. Barretto, E. Lago, and P. D. Marsden, “Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis,” Journal of Infectious Diseases, vol. 156, no. 1, pp. 73–83, 1987. View at Google Scholar
  2. M. Barral-Netto, P. Machado, and A. Barral, “Human cutaneous leishmaniasis: recent advances in physiopathology and treatment,” European Journal of Dermatology, vol. 5, no. 2, pp. 104–113, 1995. View at Google Scholar · View at Scopus
  3. C. C. Cuba, E. A. Llanos-Cuentas, A. C. Barreto et al., “Human mucocutaneous leishmaniasis in Três Braços, Bahia-Brazil, an area of Leishmania braziliensis braziliensis transmission. I. Laboratory diagnosis,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 17, pp. 161–167, 1984. View at Google Scholar
  4. K. A. Weigle, L. Valderrama, A. L. Arias, C. Santrich, and N. G. Saravia, “Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization,” American Journal of Tropical Medicine and Hygiene, vol. 44, no. 3, pp. 260–271, 1991. View at Google Scholar
  5. J. P. Sypek, C. L. Chung, S. E. H. Mayor et al., “Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response,” Journal of Experimental Medicine, vol. 177, no. 6, pp. 1797–1802, 1993. View at Google Scholar · View at Scopus
  6. O. Bacellar, H. Lessa, A. Schriefer et al., “Up-regulation of Th1-type responses in mucosal leishmaniasis patients,” Infection and Immunity, vol. 70, no. 12, pp. 6734–6740, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. L. R. V. Antonelli, W. O. Dutra, R. P. Almeida, O. Bacellar, E. M. Carvalho, and K. J. Gollob, “Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis,” Immunology Letters, vol. 101, no. 2, pp. 226–230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Machado, C. Araújo, A. T. Da Silva et al., “Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer,” Clinical Infectious Diseases, vol. 34, no. 12, pp. E69–E73, 2002. View at Google Scholar
  9. S. G. Reed, R. Badaró, H. Masur et al., “Selection of a skin test antigen for American visceral leishmaniasis,” American Journal of Tropical Medicine and Hygiene, vol. 35, no. 1, pp. 79–85, 1986. View at Google Scholar
  10. P. R. L. Machado, H. Lassa, M. Lessa et al., “Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis,” Clinical Infectious Diseases, vol. 44, no. 6, pp. 788–793, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Sadeghian and M. A. Nilforoushzadeh, “Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis,” International Journal of Dermatology, vol. 45, pp. 819–821, 2006. View at Google Scholar
  12. J. A. L. Lindoso, R. N. Barbosa, M. P. Posada-Vergara et al., “Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World,” British Journal of Dermatology, vol. 160, no. 2, pp. 311–318, 2009. View at Publisher · View at Google Scholar
  13. A. Unger, S. O'Neal, P. R. L. Machado et al., “Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in Northeastern Brazil,” American Journal of Tropical Medicine and Hygiene, vol. 80, no. 4, pp. 574–579, 2009. View at Google Scholar · View at Scopus
  14. M. G. Mendonça, A. E. F. De Brito, E. H. G. Rodrigues, V. Bandeira, M. L. Jardim, and F. G. C. Abath, “Persistence of Leishmania parasites in scars after clinical cure of american cutaneous leishmaniasis: is there a sterile cure?” Journal of Infectious Diseases, vol. 189, no. 6, pp. 1018–1023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. L. Bittencourt and A. Barral, “Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis,” Memorias do Instituto Oswaldo Cruz, vol. 86, no. 1, pp. 51–56, 1991. View at Google Scholar · View at Scopus
  16. P. Machado, J. Kanitakis, R. Almeida, A. Chalon, C. Araújo, and E. M. Carvalho, “Evidence of in situ cytotoxicity in American cutaneous leishmaniasis,” European Journal of Dermatology, vol. 12, no. 5, pp. 449–451, 2002. View at Google Scholar
  17. D. R. Faria, P. E. A. Souza, F. V. Durães et al., “Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis,” Parasite Immunology, vol. 31, no. 8, pp. 432–439, 2009. View at Publisher · View at Google Scholar
  18. E. M. Carvalho, D. C. Filho, O. Bacellar, R. P. Almeida, H. Lessa, and H. Rocha, “Characterization of the immune response in subjects with self-healing cutaneous Leishmaniasis,” American Journal of Tropical Medicine and Hygiene, vol. 53, no. 3, pp. 273–277, 1995. View at Google Scholar · View at Scopus
  19. F. Y. Liew, Y. Li, and S. Millott, “Tumour necrosis factor (TNF-α) in leishmaniasis. II. TNF-α-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine,” Immunology, vol. 71, no. 4, pp. 556–559, 1990. View at Google Scholar · View at Scopus